Welcome to Dividend.com
Please help us personalize your experience.
Select the one that best describes you

KraneShares MSCI All China Health Care Index ETF

etf
KURE
Dividend policy
Active
Price as of:
$33.14 -0.58 0%
primary theme
China Region Equity
KURE (ETF)

KraneShares MSCI All China Health Care Index ETF

Dividend policy
Active
Price as of:
$33.14 -0.58 0%
primary theme
China Region Equity
KURE (ETF)
KraneShares MSCI All China Health Care Index ETF
Dividend policy
Active
Price as of:
$33.14 -0.58 0%
primary theme
China Region Equity

KURE - Snapshot

Vitals

  • YTD Return 45.0%
  • 3 Yr Annualized Return N/A
  • 5 Yr Annualized Return N/A
  • Net Assets $131 M
  • Holdings in Top 10 45.6%

52 WEEK LOW AND HIGH

$33.72
$21.25
$36.96

Expenses

OPERATING RELATED FEES

  • Expense Ratio 0.79%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 101.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

  • Standard (Taxable) N/A
  • IRA N/A

Fund Classification

  • Primary Theme China Region Equity
  • Fund Type Exchange Traded Fund
  • Investment Style China Region

Compare KURE to Popular China Region Equity Funds

Overview

Next Dividend

Income Profile

Income Risk

Returns Profile

Allocations

Expenses

About

Dividend.com Ratings*

$18.55

-1.96%

$338.77 M

2.02%

$0.38

blocked
blocked
blocked

14.51%

-

Compare KURE to Popular China Region Equity ETFs

Overview

Next Dividend

Income Profile

Income Risk

Returns Profile

Allocations

Expenses

About

Dividend.com Ratings*

$62.30

-1.28%

$444.30 M

0.51%

$0.32

blocked
blocked
blocked

-23.89%

-

$27.99

-1.91%

$50.75 M

4.28%

$1.22

blocked
blocked
blocked

5.49%

-

$15.57

+0.32%

$47.73 M

3.18%

$0.49

blocked
blocked
blocked

-1.04%

-

$44.36

-0.96%

$23.22 M

3.22%

$1.44

blocked
blocked
blocked

30.15%

-

$21.61

-0.53%

$9.24 M

3.46%

$0.75

blocked
blocked
blocked

26.85%

-

KURE - Profile

Distributions

  • YTD Total Return 43.4%
  • 3 Yr Annualized Total Return N/A
  • 5 Yr Annualized Total Return N/A
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio 0.32%
DIVIDENDS
  • Dividend Yield 0.2%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    KraneShares MSCI All China Health Care Index ETF
  • Fund Family Name
    KraneShares
  • Inception Date
    Jan 31, 2018
  • Shares Outstanding
    3799926
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Jonathan Shelon

Fund Description

The fund will invest at least 80% of its total assets in components of the underlying index, depositary receipts, including American depositary receipts, representing such components and securities underlying depositary receipts in the underlying index. The underlying index is a free float adjusted market capitalization weighted index designed to track the equity market performance of Chinese companies engaged in the healthcare sector. The fund is non-diversified.


KURE - Performance

Return Ranking - Trailing

Period KURE Return Category Return Low Category Return High Rank in Category (%)
YTD 45.0% -23.9% 117.4% 14.02%
1 Yr 49.2% -22.0% 103.5% 16.98%
3 Yr N/A* -8.8% 23.3% N/A
5 Yr N/A* -4.2% 22.4% N/A
10 Yr N/A* -4.2% 11.3% N/A

* Annualized

Return Ranking - Calendar

Period KURE Return Category Return Low Category Return High Rank in Category (%)
2019 34.0% -1.9% 46.9% 17.00%
2018 N/A -52.1% -5.1% N/A
2017 N/A 7.9% 78.5% N/A
2016 N/A -54.3% 130.0% N/A
2015 N/A -34.4% 43.3% N/A

Total Return Ranking - Trailing

Period KURE Return Category Return Low Category Return High Rank in Category (%)
YTD 43.4% -25.0% 117.1% 16.82%
1 Yr 49.2% -22.0% 103.5% 16.04%
3 Yr N/A* -8.8% 23.3% N/A
5 Yr N/A* -4.2% 22.4% N/A
10 Yr N/A* -4.2% 11.3% N/A

* Annualized

Total Return Ranking - Calendar

Period KURE Return Category Return Low Category Return High Rank in Category (%)
2019 34.0% -1.9% 46.9% 17.00%
2018 N/A -52.1% -5.1% N/A
2017 N/A 7.9% 78.5% N/A
2016 N/A -30.2% 15.0% N/A
2015 N/A -34.4% 43.3% N/A

KURE - Holdings

Concentration Analysis

KURE Category Low Category High KURE % Rank
Net Assets 131 M 1.37 M 6.23 B 34.17%
Number of Holdings 88 26 841 31.90%
Net Assets in Top 10 60 M 800 K 3.27 B 33.62%
Weighting of Top 10 45.60% 6.4% 75.5% 66.38%

Top 10 Holdings

  1. WuXi Biologics (Cayman) Inc Registered Shs Unitary 144A/Reg S 9.45%
  2. WuXi Biologics (Cayman) Inc Registered Shs Unitary 144A/Reg S 9.45%
  3. WuXi Biologics (Cayman) Inc Registered Shs Unitary 144A/Reg S 9.45%
  4. WuXi Biologics (Cayman) Inc Registered Shs Unitary 144A/Reg S 9.45%
  5. WuXi Biologics (Cayman) Inc Registered Shs Unitary 144A/Reg S 9.45%
  6. WuXi Biologics (Cayman) Inc Registered Shs Unitary 144A/Reg S 9.45%
  7. WuXi Biologics (Cayman) Inc Registered Shs Unitary 144A/Reg S 9.45%
  8. WuXi Biologics (Cayman) Inc Registered Shs Unitary 144A/Reg S 9.45%
  9. WuXi Biologics (Cayman) Inc Registered Shs Unitary 144A/Reg S 9.45%
  10. WuXi Biologics (Cayman) Inc Registered Shs Unitary 144A/Reg S 9.45%

Asset Allocation

Weighting Return Low Return High KURE % Rank
Stocks
99.93% 64.84% 100.70% 12.07%
Cash
0.07% -0.70% 16.68% 87.07%
Preferred Stocks
0.00% 0.00% 0.00% 15.52%
Other
0.00% -3.32% 31.90% 22.41%
Convertible Bonds
0.00% 0.00% 0.00% 15.52%
Bonds
0.00% 0.00% 0.02% 17.24%

KURE - Expenses

Operational Fees

KURE Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.79% 0.09% 20.07% 65.74%
Management Fee 0.78% 0.09% 1.50% 45.83%
12b-1 Fee 0.00% 0.00% 1.00% 8.33%
Administrative Fee N/A 0.03% 0.26% N/A

Sales Fees

KURE Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 3.50% 5.75% N/A
Deferred Load N/A 1.00% 1.00% N/A

Trading Fees

KURE Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 2.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

KURE Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 101.00% 0.00% 344.00% 82.52%

KURE - Distributions

Dividend Yield Analysis

KURE Category Low Category High KURE % Rank
Dividend Yield 0.17% 0.00% 9.35% 35.00%

Dividend Distribution Analysis

KURE Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Annually Annually

Net Income Ratio Analysis

KURE Category Low Category High KURE % Rank
Net Income Ratio 0.32% -2.12% 4.44% 66.36%

Capital Gain Distribution Analysis

KURE Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually Annually

Dividend Payout History

View More +

KURE - Fund Manager Analysis

Managers

Jonathan Shelon


Start Date

Tenure

Tenure Rank

Aug 01, 2018

2.25

2.3%

Jonathan Shelon, Managing Partner and Chief Operating Officer at Krane, also serves as a portfolio manager of each Fund and supports Mr. Schlarbaum and Krane’s investment team with respect to each Fund. Mr. Shelon has been a portfolio manager of each Fund since August 2018 (in the case of KraneShares CSI China Internet ETF, KraneShares Electric Vehicles and Future Mobility Index ETF, KraneShares Emerging Markets Consumer Technology Index ETF, KraneShares MSCI All China Healthcare Index ETF, KraneShares MSCI All China Index ETF, KraneShares MSCI China Environment Index ETF, KraneShares MSCI One Belt One Road Index ETF and KraneShares Zacks New China ETF) or since inception (in the case of KraneShares Emerging Markets Healthcare Index ETF, KraneShares MSCI All China Consumer Discretionary Index ETF, KraneShares MSCI All China Consumer Staples Index ETF and KraneShares MSCI China A Inclusion Hedged Index ETF,). Mr. Shelon joined Krane in 2015 as a Managing Partner. Mr. Shelon has spent the majority of his career managing investment portfolios and diverse teams at leading asset management organizations. Most recently, he was the Chief Investment Officer of a 40-person global Specialized Strategies Team at J.P. Morgan with $40 billion AUM. Prior to joining J.P. Morgan, Mr. Shelon spent ten years as a portfolio manager at Fidelity Investments since 2001 where he was responsible for the investment performance, process and evolution of their target-date strategies for retirement savings, college savings and income generation. Prior to joining, he was a quantitative consultant at Callan Associates, Inc.

James Maund


Start Date

Tenure

Tenure Rank

Jan 14, 2020

0.8

0.8%

James Maund, Head of Capital Markets at Krane Funds Advisors LLC. He joined the Krane Funds Advisors in 2020 and has been in the investment management industry since 2005. Previously, he was a Vice President in the Institutional ETF Group and a member of the ETF Capital Markets Group at State Street Global Advisors (2010-2019); and an ETF trader at Goldman Sachs & Co (2005-2010). Mr. Maund graduated with a bachelor’s degree in economics from Wesleyan University.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.01 26.74 3.57 1.84

Continue to site >
Trending ETFs